Detailed price information for Briacell Therapeutics Corp (BCTX-Q) from The Globe and Mail including charting and trades.
Minovia Therapeutics Ltd. (“Minovia” or the “Company”), a clinical-stage biotechnology company developing novel therapies to treat mitochondrial diseases and combat age-related decline, announces that ...
Background Hypothyroidism has been suggested as a predisposing and prognostic factor in patients with spontaneous coronary ...
By implementing appropriate security measures, threat assessment protocols, and compliance-driven policies, healthcare ...
Olema Pharmaceuticals (OLMA) surges after Roche's breast cancer data, but caution is urged as key clinical results are ...
Funding advances Phase 2 expansion cohorts in pancreatic and colorectal cancer in ATM-negative patients for Artios’ potential first-in-class ATR Inhibitor, alnodesertib Following encouraging ESMO data ...
Aspen Neuroscience, Inc., a clinical-stage biotechnology company pioneering autologous regenerative therapies, today ...
Detailed price information for Chemomab Therapeutics Ltd ADR (CMMB-Q) from The Globe and Mail including charting and trades.
As a global leader in neuroscience, Neuronetics is delivering more treatment options to patients and physicians by offering exceptional in-office treatments that produce extraordinary results.
Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical stage company developing product candidates designed to treat neurodegenerative disorders, announced that the Company’s president and CEO, Lisa ...
How Cell And Gene Therapy Could Redefine Chronic Disease Treatment. Five companies are racing to bring CRISPR-based and ...
The 52-week symptom data reported for Cohort 6 patients is consistent with the long-term durability data previously reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback